Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

Eli Lilly announces encouraging data from Alzheimer's disease study

Eli Lilly and Company has announced new data showing that beta-amyloid imaging was associated with altered diagnosis and management of patients with Alzheimer's disease.

Published By MarketLine
18 Jul 2014
NewsWire
NewsWire

Highmark and ACMH announce multi-year contract extension

Highmark Inc., a health insurance company, and Armstrong County Memorial Hospital, or ACMH, have announced a multi-year contract extension that will ensure Highmark Blue Cross Blue Shield members have access to the Kittanning, Pennsylvania-based hospital.

Published By MarketLine
18 Jul 2014
NewsWire
NewsWire

Foscote installs Carestream Standard-Q Room and Mobile Retrofit imaging systems

The Foscote Hospital has installed a Carestream DRX-Evolution Standard-Q Room and a Carestream DRX Mobile Retrofit unit complete with two DRX detectors.

Published By MarketLine
18 Jul 2014
NewsWire
NewsWire

Thermo Fisher unveils new liquid chromatography system

Thermo Fisher Scientific Inc., a provider of diagnostics and laboratory products, has unveiled Thermo Scientific Vanquish UHPLC, a new liquid chromatography system designed to provide new levels of performance, productivity and usability when used as a standalone system or with the latest mass spectrometers.

Published By MarketLine
18 Jul 2014
NewsWire
NewsWire

Covidien unveils new soft tissue ablation system

Covidien plc, a developer of medical device and supply products, has unveiled Emprint Ablation System, an ablation system that reportedly offers physicians predictable results regardless of the target location or tissue type.

Published By MarketLine
18 Jul 2014
NewsWire
NewsWire

Johnson & Johnson reports higher Q2 net earnings, provides outlook for 2014

Johnson & Johnson has reported that net earnings for the second quarter of 2014 were $4.33 billion, or $1.51 per diluted share, compared to $3.83 billion, or $1.33 per diluted share, for the same quarter of 2013. For 2014, the company expects earnings to be in the range of $5.85 to $5.92 per share.

Published By MarketLine
18 Jul 2014
NewsWire
NewsWire

Novartis and BAI collaborate for Alzheimer's disease study

Novartis AG has announced collaboration with Banner Alzheimer's Institute, or BAI, on a clinical study in Alzheimer's disease, or AD, prevention.

Published By MarketLine
18 Jul 2014
NewsWire
NewsWire

Palatin receives USPTO notice of allowance for melanocortin receptor 1 peptides

Palatin Technologies, Inc., a biopharmaceutical company, has received a notice of allowance from US Patent and Trademark Office, or USPTO, for melanocortin receptor 1 specific peptides. The application includes composition of matter claims on broad families of melanocortin receptor 1 specific peptides with potential utility for treatment of inflammatory diseases and disorders.

Published By MarketLine
18 Jul 2014
NewsWire
NewsWire

Illumina names senior vice president of oncology business

Illumina Inc., a developer of integrated systems for the analysis of genetic variation and biological function, has named Tina Nova as senior vice president and general manager of the company's oncology business.

Published By MarketLine
18 Jul 2014
NewsWire
NewsWire

Bio-Rad launches new human metabolic and hormone immunoassays

Bio-Rad Laboratories, Inc., a provider of products for life science research and clinical diagnostic markets, has launched its new Bio-Plex Pro RBM human metabolic and hormone assays.

Published By MarketLine
18 Jul 2014

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.